GoldBamboo.com - Knowledge is strong medicine
  

Study of the Composition of Dental Plaque - Article


  Not Signed In - Sign In / Register






Dental Health

Dental/ Oral Health


Clinical Trial: Study of the Composition of Dental Plaque

This study is currently recruiting patients.

Sponsored by: National Institute of Dental and Craniofacial Research (NIDCR)
Information provided by: Warren G Magnuson Clinical Center (CC)

Purpose

This study will examine the composition of dental plaque-a naturally occurring substance that sticks to the teeth and can cause tooth decay and gum disease. A better understanding of how plaque builds up in the mouth may help in developing improved ways of controlling it.

Healthy normal volunteers between the ages of 18 and 65 who work at the National Institutes of Health main campus in Bethesda, Maryland, may participate in this study. Candidates will be screened for eligibility with a medical and dental history.

This study involves a maximum of five visits to the dental clinic. At the first visit, participants will have a dental examination, and a mold will be made of the mouth. To make the mold, a small plastic tray containing impression material will be placed in the volunteer's mouth and held in place for about 2 minutes to set. The tray will then be removed and a mold will be made from the impression. The mold will be used to make the mouthpiece used in study 1, described below, and the tooth fittings used in study 2, also described below. Volunteers will participate in one of these two studies.

Study 1. Volunteers in study 1 will have their mouthpiece checked at the second visit, have a teeth cleaning, and have the mold put in place. The mouthpiece will be worn for up to 8 hours, during which time soft foods can be eaten. Mouthwash should not be used while the device is in place. At the volunteer's third (last) visit, the mouthpiece will be removed and the volunteer will spit into a tube to collect saliva for examination for bacteria.

Study 2. Volunteers in study 2 will have their teeth cleaned at the second visit and the tooth fittings placed onto the back teeth with a dental adhesive. The fittings will be worn for up to 72 hours, during which time volunteers can eat a regular diet and brush their teeth. Mouthwash should not be used while the fittings are in place. At the third, fourth and fifth visits, some of the fittings will be removed and, if necessary, the tooth surface will be polished. The last of the fittings will be removed at the fifth visit and the volunteer will spit into a tube to collect saliva for examination for bacteria.

Condition
Dental Caries
Dental Plaque
Periodontal Disease

MedlinePlus related topics:  Gum Disease;   Tooth Disorders

Study Type: Observational
Study Design: Natural History

Official Title: Spatial Organization of Viridans Streptococci in Oral Biofilms

Further Study Details: 

Expected Total Enrollment:  50

Study start: June 19, 1998

Dental caries and periodontal disease are closely associated with dental plaque, the biofilm that results from microbial colonization of the tooth surface. Various experimental models have been described for the initial phase of colonization, including one that utilizes enamel chips positioned within the oral cavity for periods of time up to 24 hours. Scanning electron microscopy of chips removed after 4 hrs in vivo revealed individual bacteria attached to the pellicle-coated surface. Growth of these pioneer organisms resulted in microcolonies that merged to form a spreading monolayer of cocci and rods. Further growth resulted in a bacterial multilayer typical of supragingival dental plaque. Over 80% of the bacteria present in early biofilms were identified as members of four closely related viridans streptococcal species, Streptococcus sanguis, S. oralis, S. mitis and S. gordonii. The rod-shaped bacteria which accounted for another 10% of the total, were primarily strains of Actinomyces naeslundii. Interestingly, the proportions of actinomyces and S. oralis both increased during the first 24 hrs of colonization thereby suggesting important roles for these bacteria in normal daily plaque accumulation [early biofilm development].

One of the major uncertainties raised by the wide-spread ability of cells of oral bacteria to interact physically in vitro is whether these coaggregations function in vivo. Using direct immunofluorescence, we have demonstrated the coincident juxtaposition in dental plaque of streptococci and actinomyces, suggesting that these known coaggregating partners may use coaggregation as a means to colonize oral surfaces in vivo. Our overall goal is to determine spatial organization of different viridans streptococci in biofilms that form during initial colonization of the tooth surface. These bacteria include two groups with distinctive properties. One group contains strains of Streptococcus sanguis and S. Gordonii with GalNAc-sensitive adhesions and the other contains strains of S. oralis and other species with complementary receptors for intrageneric coaggregation. Streptococci in these groups can be distinguished antigenically since only the former are positive for the Lancefield Group H antigen (H-streptococci) and the latter are positive for specific cell wall receptor polysaccharides (Ps-streptococci). Biofilms with H- and Ps-streptococci will be formed with known early colonizers in vitro, using human saliva and a flow cell model, and in vivo within the human oral cavity. Expanding that observation to studies of the interactions of H- and Ps-streptococci in early plaque formed in vivo is proposed to address the hypothesis that intrageneric cell-to-cell adherence is central to explaining the prevalence of streptococci in the first 4 hours of plaque biofilm. The removable enamel chip model used successfully by the laboratories of William Liljemark and Mogens Kilian will be used. We will use the H- and Ps- specific monoclonal antibodies to identify the spatial organization of the adherent cells representing these two groups of streptococci. Monoclonal antibodies will be prepared against these surface antigens and used as probes in scanning confocal laser microscopy to examine the spatial organization of the two groups of streptococci in experimental and clinically observed biofilms. The models for biofilm formation will include an in vitro flow-cell model in which streptococci with known adhesive properties attach and grow on a saliva-coated surface and an in vivo model in which enamel chips are colonized within the oral cavity for periods of time up to 72 hours. The results of these studies should provide significant insights into the involvement of interbacterial adhesion in biofilm development. Our goal from these studies is to investigate the spatial organization of Ps- and H-streptococci in biofilms formed in vivo compared to in vitro. We hope to make significant advances in understanding the distribution of these two groups of streptococci in initial dental plaque formation. Since the streptococci are the predominant organism in early dental plaque, we propose that understanding their contribution to microbial communities will lead to important advances in designing effective oral health regimens.

Eligibility

Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

INCLUSION CRITERIA:
Aged 18 to 65 years
EXCLUSION CRITERIA:
History of medical conditions affecting salivary flow.
History of immunosuppressant therapy.
Use of tobacco.
Use of antibiotics within the preceding four months.
Use of medications thought to affect salivary flow.
Missing any maxillary premolar, first, or second molar.
Unwilling or unable to give informed consent.

Location and Contact Information


Maryland
      National Institute of Dental And Craniofacial Research (NIDCR), 9000 Rockville Pike,  Bethesda,  Maryland,  20892,  United States; Recruiting
Patient Recruitment and Public Liaison Office  1-800-411-1222    prpl@mail.cc.nih.gov 
TTY  1-866-411-1010 

More Information

Detailed Web Page

Publications

Bos R, van der Mei HC, Busscher HJ. Co-adhesion of oral microbial pairs under flow in the presence of saliva and lactose. J Dent Res. 1996 Feb;75(2):809-15.

Cisar JO, Sandberg AL, Reddy GP, Abeygunawardana C, Bush CA. Structural and antigenic types of cell wall polysaccharides from viridans group streptococci with receptors for oral actinomyces and streptococcal lectins. Infect Immun. 1997 Dec;65(12):5035-41.

Frandsen EV, Pedrazzoli V, Kilian M. Ecology of viridans streptococci in the oral cavity and pharynx. Oral Microbiol Immunol. 1991 Jun;6(3):129-33.

Study ID Numbers:  980116; 98-D-0116
Record last reviewed:  May 23, 2004
Last Updated:  November 23, 2004
Record first received:  November 3, 1999
ClinicalTrials.gov Identifier:  NCT00001726
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Dental Health.

October 13, 2008



Page Updated: December 9, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.